Identification of Biomarkers by ORFeome Phage Display

  • Check with publisher
  • Published date: October 30, 2019
    • Shirley, New York, United States

The identification of biomarkers from pathogens is a prerequisite for the development of vaccines and diagnostic assays. Creative Biolabs developed an extensive and comprehensive strategy, named ORFeome phage display, for the identification of biomarkers related to pathogens. We apply this technology to identify new biomarkers by using bacterial genome libraries. We are proud to introduce this service for new biomarkers identification to all our global customers. https://www.creative-biolabs.com/drug-discovery/therapeutics/identification-of-biomarkers-by-orfeome-phage-display.htm .

Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Magic™ Humanized TIGIT Immune Checkpoint Knock-In Mice

    Magic™ Humanized TIGIT Immune Checkpoint Knock-In Mice

    Biomedical Sciences Shirley (New York) October 30, 2019 Check with publisher

    Immune-oncology research is greatly stimulated by the clinical success of immune checkpoint modulators which lead to the identification of new tumor immunology targets. However, drug development and assessment of immune checkpoint modulators need app...

  • Other Motor Function Tests

    Other Motor Function Tests

    Biomedical Sciences Shirley (New York) October 30, 2019 Check with publisher

    Creative Biolabs conducts a wide range of behavioral tests to assess motor impairments across different models of the central nervous system (CNS), including but not limited to Parkinson's disease, Huntington disease, traumatic brain injury, stroke, ...

  • Drug Dependence Liability/Withdrawal Test

    Drug Dependence Liability/Withdrawal Test

    Biomedical Sciences Shirley (New York) October 30, 2019 Check with publisher

    A key component in abuse liability testing is the appropriate evaluation of an objectively verified potential withdrawal or discontinuation syndrome induced by high dose chronic administration of the test article. Creative Biolabs conducts drug depen...